For CRAO/CRVO or submacular hemorrhage caused by AMD, the intra-vascular injection of tissue plasminogen activator solution (tPA) or subretinal injection of air and tPA has emerged as a new therapeutic approach [5,6]. This evidence concerns the gene PLAT and age-related macular degeneration.